Status:
COMPLETED
Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)
Lead Sponsor:
Bayer
Collaborating Sponsors:
Janssen Scientific Affairs, LLC
Conditions:
Venous Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this NIS is to assess in a real-life setting, usage patterns and associated outcomes in the management (healthcare resource utilisation and associated costs) of patients with acute de...
Eligibility Criteria
Inclusion
- Adult patients with a diagnosis of deep vein thrombosis (DVT) within the past 9 months, enabling at least 3 months of therapy
Exclusion
- Patients who do not fulfil the Belgian reimbursement criteria of deep vein thrombosis (DVT)
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
131 Patients enrolled
Trial Details
Trial ID
NCT01855100
Start Date
July 1 2013
End Date
December 1 2014
Last Update
January 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Belgium